US Stock MarketDetailed Quotes

TRML Tourmaline Bio

Watchlist
  • 23.750
  • +0.740+3.22%
Close Nov 25 16:00 ET
  • 23.080
  • -0.670-2.82%
Pre 05:58 ET
609.01MMarket Cap-11467P/E (TTM)

Tourmaline Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
267.88%24.44M
34.18%21.97M
133.50%17.52M
130.49%45.41M
140.30%14.89M
-66.49%6.64M
16.37M
7.5M
19.7M
-16,450.00%-36.95M
Selling and administrative expenses
77.30%5.11M
224.84%6.24M
349.89%6.14M
499.59%13.04M
156.76%6.88M
-40.50%2.88M
--1.92M
--1.37M
--2.18M
-7,101.73%-12.11M
-General and administrative expense
77.30%5.11M
224.84%6.24M
349.89%6.14M
499.59%13.04M
156.76%6.88M
-40.50%2.88M
--1.92M
--1.37M
--2.18M
-7,101.73%-12.11M
Research and development costs
413.82%19.33M
8.86%15.73M
85.37%11.38M
84.69%32.37M
132.27%8.02M
-74.89%3.76M
--14.45M
--6.14M
--17.53M
-46,964.15%-24.84M
Operating profit
-267.88%-24.44M
-34.18%-21.97M
-133.50%-17.52M
-130.49%-45.41M
-140.30%-14.89M
66.49%-6.64M
-16.37M
-7.5M
-19.7M
16,450.00%36.95M
Net non-operating interest income expense
Other net income (expense)
305.04%4.26M
1,730.20%4.48M
4.21M
3.29M
1.99M
1.05M
245K
Other non- operating income (expenses)
305.04%4.26M
1,730.20%4.48M
--4.21M
--3.29M
--1.99M
--1.05M
--245K
----
----
----
Income before tax
-260.88%-20.18M
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-136.18%-12.9M
70.59%-5.59M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
Income tax
Net income
-260.88%-20.18M
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-136.18%-12.9M
70.59%-5.59M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
Net income continuous Operations
-260.88%-20.18M
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-136.18%-12.9M
70.59%-5.59M
---16.13M
---7.5M
---19.7M
15,880.97%35.67M
Minority interest income
Net income attributable to the parent company
-260.88%-20.18M
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-136.18%-12.9M
70.59%-5.59M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-260.88%-20.18M
-8.42%-17.49M
-77.43%-13.31M
-113.82%-42.12M
-136.18%-12.9M
70.59%-5.59M
-16.13M
-7.5M
-19.7M
15,880.97%35.67M
Basic earnings per share
-183.72%-0.78
14.26%-0.68
-49.10%-0.55
-815.62%-8.87
-136.17%-0.6344
70.59%-0.2749
-0.7931
-0.3689
-0.9687
15,880.80%1.7537
Diluted earnings per share
-183.72%-0.78
14.26%-0.68
-49.10%-0.55
-815.62%-8.87
-136.17%-0.6344
70.59%-0.2749
-0.7931
-0.3689
-0.9687
15,880.80%1.7537
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 267.88%24.44M34.18%21.97M133.50%17.52M130.49%45.41M140.30%14.89M-66.49%6.64M16.37M7.5M19.7M-16,450.00%-36.95M
Selling and administrative expenses 77.30%5.11M224.84%6.24M349.89%6.14M499.59%13.04M156.76%6.88M-40.50%2.88M--1.92M--1.37M--2.18M-7,101.73%-12.11M
-General and administrative expense 77.30%5.11M224.84%6.24M349.89%6.14M499.59%13.04M156.76%6.88M-40.50%2.88M--1.92M--1.37M--2.18M-7,101.73%-12.11M
Research and development costs 413.82%19.33M8.86%15.73M85.37%11.38M84.69%32.37M132.27%8.02M-74.89%3.76M--14.45M--6.14M--17.53M-46,964.15%-24.84M
Operating profit -267.88%-24.44M-34.18%-21.97M-133.50%-17.52M-130.49%-45.41M-140.30%-14.89M66.49%-6.64M-16.37M-7.5M-19.7M16,450.00%36.95M
Net non-operating interest income expense
Other net income (expense) 305.04%4.26M1,730.20%4.48M4.21M3.29M1.99M1.05M245K
Other non- operating income (expenses) 305.04%4.26M1,730.20%4.48M--4.21M--3.29M--1.99M--1.05M--245K------------
Income before tax -260.88%-20.18M-8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-136.18%-12.9M70.59%-5.59M-16.13M-7.5M-19.7M15,880.97%35.67M
Income tax
Net income -260.88%-20.18M-8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-136.18%-12.9M70.59%-5.59M-16.13M-7.5M-19.7M15,880.97%35.67M
Net income continuous Operations -260.88%-20.18M-8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-136.18%-12.9M70.59%-5.59M---16.13M---7.5M---19.7M15,880.97%35.67M
Minority interest income
Net income attributable to the parent company -260.88%-20.18M-8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-136.18%-12.9M70.59%-5.59M-16.13M-7.5M-19.7M15,880.97%35.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -260.88%-20.18M-8.42%-17.49M-77.43%-13.31M-113.82%-42.12M-136.18%-12.9M70.59%-5.59M-16.13M-7.5M-19.7M15,880.97%35.67M
Basic earnings per share -183.72%-0.7814.26%-0.68-49.10%-0.55-815.62%-8.87-136.17%-0.634470.59%-0.2749-0.7931-0.3689-0.968715,880.80%1.7537
Diluted earnings per share -183.72%-0.7814.26%-0.68-49.10%-0.55-815.62%-8.87-136.17%-0.634470.59%-0.2749-0.7931-0.3689-0.968715,880.80%1.7537
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data